Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TREATMENT OF MULTIPLE SCLEROSIS WITH ANTI-CD19 ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2013/138244
Kind Code:
A3
Abstract:
The present method provides for the treatment of multiple sclerosis through the use of chimeric and humanized versions of anti -CD19 antibodies that may mediate ADCC, CDC, and/or apoptosis.

More Like This:
WO/1996/025518PROBE FOR USE IN NUCLEIC ACID ANALYSIS AND DETECTING METHOD
WO/1998/046724RECOMBINANT bHLH-PAS/JHR POLYPEPTIDE AND ITS USE TO SCREEN POTENTIAL INSECTICIDES
WO/2000/050092ANTISENSE MODULATION OF SMAD1 EXPRESSION
Inventors:
HERBST RONALD (US)
KNAPPERTZ VOLKER ARMIN (US)
CARTER LAURA LEE (US)
WANG YUE (US)
Application Number:
PCT/US2013/030247
Publication Date:
December 24, 2014
Filing Date:
March 11, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDIMMUNE LLC (US)
International Classes:
C07H21/04; A61K39/00; C12N5/07; C12P21/08
Foreign References:
US20080138336A12008-06-12
US20100158903A12010-06-24
Other References:
See also references of EP 2827902A4
Attorney, Agent or Firm:
COHEN, Jared et al. (LLCOne Medimmune Wa, Gaithersburg MD, US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: BIFUNCTIONAL COMPOUNDS

Next Patent: LEADING END ASSEMBLIES FOR MOVABLE PARTITIONS, MOVABLE PARTITIONS AND RELATED METHODS